Fluorine-18 FluoroDesoxyGlucose (18FDG) positron emission tomography (PET/CT) plays an important role in cancer management. Despite the fact that the hybrid camera uses a non-diagnostic scanner, it contributes to additional patient irradiation. The aim was to evaluate the additional effective dose delivered by CT to 18 FDG PET in an adult population who received this examination. This prospective study included 35 patients aged from 19 to 81 years, with a sex ratio of 1.69 F/H. The mean effective dose of the PET part was 4.560 mSv, with extremes ranging from 2.263 to 7.44 mSv. The mean...

Bronchopulmonary cancer represents a real public health problem. The aim of our work is to demonstrate the additional contribution of positron emission tomography coupled with 18F-fluoro deoxy-glucose computed tomography (18FDG PET-CT), both locally and remotely, in optimizing the management of non-small cell bronchopulmonary cancers. In the initial preoperative workup, PET-CT allowed us to modify the stage in 69% of cases with up staging in 6 patients and down staging in 3 patients. In addition, PET-CT allowed us to find a suspicious hypermetabolic breast nodule in one case. For recurrence...

Die hybride metastabile Technetium-99-markierte Methoxyisobutylisonitril(99mTc-MIBI)-Bildgebung spielt eine wichtige Rolle bei der Diagnose und Behandlung von Hyperparathyreoidismus. Ziel dieser Studie ist es, den Wert der 99mTc-MIBI-Einzelphotonen-Emissions-Computertomographie (SPECT)/Computertomographie (CT) im Vergleich zur planaren Bildgebung darzustellen .Diese prospektive Studie schloss 60 Patienten im Alter von 17 bis 92 Jahren ein, mit einem Geschlechterverhältnis von 14:1. Die planare Bildgebung zeigte in 15 Fällen ein Nebenschilddrüsenadenom, war in 44 Fällen normal und in einem...

Positron emission tomography coupled with 2-deoxy-2-18F-fluoro-D-glucose computed tomography (18FDG PET/CT) has become established at various stages of cancer management. The aim of this prospective study, including 60 patients, was to evaluate the contribution of 18FDG PET/CT in an oncologic population that had benefited from this examination. The mean age was 39 years, with a sex ratio of 0.7. The 18FDG PET/CT scan was performed as part of an initial extension workup (13%), early mid-treatment evaluation (5%), end-of-treatment evaluation (49%), recurrence search and workup (29%), and search...